Selective l-nitroargininylaminopyrrolidine and l-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors

Jiwon Seo, Pavel Martásek, Linda J. Roman, Richard B. Silverman

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Selective inhibition of the localized excess production of NO by neuronal nitric oxide synthase (nNOS) has been targeted as a potential means of treating various neurological disorders. Based on observations from the X-ray crystal structures of complexes of nNOS with two nNOS-selective inhibitors, (4S)-N-{4-amino-5-[(2-amino)ethylamino]pentyl}-N′-nitroguanidine (l-Arg(NO2)-l-Dbu-NH2 (1) and 4-N-(Nω-nitro-l-argininyl)-trans-4-amino-l-proline amide (2), a series of descarboxamide analogues was designed and synthesized (3-7). The most potent compound was aminopyrrolidine analogue 3, which exhibited better potency and selectivity for nNOS than parent compound 2. In addition, 3 provided higher lipophilicity and a lower molecular weight than 2, therefore having better physicochemical properties. Nα-Methylated analogues (8-11) also were prepared for increased lipophilicity of the inhibitors, but they had 4- to 5-fold weaker binding affinity compared to their parent compounds.

Original languageEnglish (US)
Pages (from-to)1928-1938
Number of pages11
JournalBioorganic and Medicinal Chemistry
Volume15
Issue number5
DOIs
StatePublished - Mar 1 2007

Fingerprint

Nitric Oxide Synthase Type I
Nervous System Diseases
Proline
Amides
Crystal structure
Molecular Weight
Molecular weight
X-Rays
X rays

Keywords

  • Aminopiperidines
  • Aminopyrrolidines
  • Enzyme inhibitors
  • Neuronal nitric oxide synthase
  • Selective inhibition

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Selective l-nitroargininylaminopyrrolidine and l-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors. / Seo, Jiwon; Martásek, Pavel; Roman, Linda J.; Silverman, Richard B.

In: Bioorganic and Medicinal Chemistry, Vol. 15, No. 5, 01.03.2007, p. 1928-1938.

Research output: Contribution to journalArticle

Seo, Jiwon ; Martásek, Pavel ; Roman, Linda J. ; Silverman, Richard B. / Selective l-nitroargininylaminopyrrolidine and l-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors. In: Bioorganic and Medicinal Chemistry. 2007 ; Vol. 15, No. 5. pp. 1928-1938.
@article{3d16d5969ef2490c9e0620d046ed13b2,
title = "Selective l-nitroargininylaminopyrrolidine and l-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors",
abstract = "Selective inhibition of the localized excess production of NO by neuronal nitric oxide synthase (nNOS) has been targeted as a potential means of treating various neurological disorders. Based on observations from the X-ray crystal structures of complexes of nNOS with two nNOS-selective inhibitors, (4S)-N-{4-amino-5-[(2-amino)ethylamino]pentyl}-N′-nitroguanidine (l-Arg(NO2)-l-Dbu-NH2 (1) and 4-N-(Nω-nitro-l-argininyl)-trans-4-amino-l-proline amide (2), a series of descarboxamide analogues was designed and synthesized (3-7). The most potent compound was aminopyrrolidine analogue 3, which exhibited better potency and selectivity for nNOS than parent compound 2. In addition, 3 provided higher lipophilicity and a lower molecular weight than 2, therefore having better physicochemical properties. Nα-Methylated analogues (8-11) also were prepared for increased lipophilicity of the inhibitors, but they had 4- to 5-fold weaker binding affinity compared to their parent compounds.",
keywords = "Aminopiperidines, Aminopyrrolidines, Enzyme inhibitors, Neuronal nitric oxide synthase, Selective inhibition",
author = "Jiwon Seo and Pavel Mart{\'a}sek and Roman, {Linda J.} and Silverman, {Richard B.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.bmc.2007.01.001",
language = "English (US)",
volume = "15",
pages = "1928--1938",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Selective l-nitroargininylaminopyrrolidine and l-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors

AU - Seo, Jiwon

AU - Martásek, Pavel

AU - Roman, Linda J.

AU - Silverman, Richard B.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Selective inhibition of the localized excess production of NO by neuronal nitric oxide synthase (nNOS) has been targeted as a potential means of treating various neurological disorders. Based on observations from the X-ray crystal structures of complexes of nNOS with two nNOS-selective inhibitors, (4S)-N-{4-amino-5-[(2-amino)ethylamino]pentyl}-N′-nitroguanidine (l-Arg(NO2)-l-Dbu-NH2 (1) and 4-N-(Nω-nitro-l-argininyl)-trans-4-amino-l-proline amide (2), a series of descarboxamide analogues was designed and synthesized (3-7). The most potent compound was aminopyrrolidine analogue 3, which exhibited better potency and selectivity for nNOS than parent compound 2. In addition, 3 provided higher lipophilicity and a lower molecular weight than 2, therefore having better physicochemical properties. Nα-Methylated analogues (8-11) also were prepared for increased lipophilicity of the inhibitors, but they had 4- to 5-fold weaker binding affinity compared to their parent compounds.

AB - Selective inhibition of the localized excess production of NO by neuronal nitric oxide synthase (nNOS) has been targeted as a potential means of treating various neurological disorders. Based on observations from the X-ray crystal structures of complexes of nNOS with two nNOS-selective inhibitors, (4S)-N-{4-amino-5-[(2-amino)ethylamino]pentyl}-N′-nitroguanidine (l-Arg(NO2)-l-Dbu-NH2 (1) and 4-N-(Nω-nitro-l-argininyl)-trans-4-amino-l-proline amide (2), a series of descarboxamide analogues was designed and synthesized (3-7). The most potent compound was aminopyrrolidine analogue 3, which exhibited better potency and selectivity for nNOS than parent compound 2. In addition, 3 provided higher lipophilicity and a lower molecular weight than 2, therefore having better physicochemical properties. Nα-Methylated analogues (8-11) also were prepared for increased lipophilicity of the inhibitors, but they had 4- to 5-fold weaker binding affinity compared to their parent compounds.

KW - Aminopiperidines

KW - Aminopyrrolidines

KW - Enzyme inhibitors

KW - Neuronal nitric oxide synthase

KW - Selective inhibition

UR - http://www.scopus.com/inward/record.url?scp=33846562999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846562999&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2007.01.001

DO - 10.1016/j.bmc.2007.01.001

M3 - Article

C2 - 17239601

AN - SCOPUS:33846562999

VL - 15

SP - 1928

EP - 1938

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 5

ER -